14 March, 2005
Eurovestech Plc ('Eurovestech')
Directors' dealings and variation of terms of warrants
Under a warrant instrument dated 2 March 2000, Eurovestech granted warrants to
subscribe for 29,500,000 Ordinary Shares, in aggregate, at an exercise price of
10p per share ('Warrants'). On 11 March 2005, the Company received notification
that 3,150,000 Warrants had been exercised, including 1,000,000 by Richard
Bernstein, Chief Executive, and 150,000 by Jean-Michel Petit, Investment
Director.
Under the terms of the warrant instrument, the Warrants were due to lapse on 13
March 2005. The Remuneration Committee has resolved to extend the exercise
period of the Warrants to 13 March 2010 and to increase the exercise price to
20p per share. On 11 March 2005, the Company received notification from all
remaining warrants holders agreeing to the variation.
Certain of the directors of Eurovestech hold the following number of Warrants:
Richard Bernstein 19,000,000
Jean-Michel Petit 1,550,000
Richard Grogan 1,000,000
Application will be made for 3,150,000 Ordinary Shares to be admitted to
trading on AIM and dealings are expected to commence on 21 March 2005.
Further enquiries:
Eurovestech Plc
Richard Bernstein
Chief Executive Tel: 020 7491 0770
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.